Oxytocin is a lifesaving drug - it is one of the 13 commodities on the list of the United Nations Commission on Life-Saving Commodities for Women and Children. - See more at:
Oxytocin is temperature sensitive and in several countries studies have demonstrated that the product has lost some, to most of its potency by the time it reaches the women who need it most (those that give birth in remote areas.) In many cases this can be attributed to exposure to high temperatures during transport or storage (e.g. in clinics without air conditioned storage rooms)
On the other hand in some peripheral health centers oxytocin is stored in the cold chain and midwifes assure that it is available in the delivery room by putting it in the cold boxes they use for storing vaccines such as VAT and BCG. However, if the oxytocin has reached the health center outside of the cold box the product may have lost some or all of its potency.
What would be the dis-advantage of assuring that oxytocin is included in the cold chain from the point of entry of the country till it reaches the delivery room? Are there any countries who currently have oxytocin in the cold chain?
Please share your experience and thoughts.